The cardiac mapping devices market offers opportunities driven by rising cardiovascular diseases, an aging population, and a ...
ASX healthcare rises for week ending January 23, 2026 as Morgans' Scott Power says focus shifts to quarterly reporting season ...
The futures are trading lower again after a dreadful risk-off day across Wall Street, where all major indices finished the ...
A quiet, nagging question always lingered in the back of my mind: Was that flutter just stress, or was I having a heart attack? I would feel a skip, a thud, or sometimes a rush. I would try to “listen ...
EU considers $108B in tariffs and market restrictions on the U.S. after Trump's Greenland threats, raising trade tensions.
In recent days, Flutter Entertainment plc announced that David Kenny, Chairman of Best Buy and former Nielsen CEO, will join its board as an independent non-executive director following the 29 May ...
Heard a chirp or spotted a flutter? These free apps identify backyard birds by sight or sound — no binoculars or in-depth ...
AccurKardia, an ECG-led diagnostics software company focused on transforming ECG data into a more powerful diagnostic tool and broad biomarker to improve patient outcomes and save lives, today ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...
If you’ve recently checked your Microsoft account online to manage your devices and found the list empty or missing a computer you use every day, you’re facing a common but frustrating issue. This ...
In a pre-Christmas rush, biotechs report a flurry of clinical activity Radiopharm shares surge up to 22% on strong brain-imaging results Morgans says Sigma Health and EBOS Group shares are just the ...
The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side ...